ADHD Assessment Demand Forecaster for NHS Commissioners
A forecasting service that turns real primary-care incidence trends into multi-year ADHD assessment demand projections, so NHS commissioners and private assessment providers can size clinics and waiting lists with numbers instead of anecdotes.
Concept
A subscription analytics product for NHS commissioners and independent ADHD assessment providers. It combines local population demographics with the age- and sex-stratified incidence curves now measurable from primary-care records, and models referral volumes under several scenarios: continuation of the post-2020 acceleration, plateau at current rates, and convergence toward published prevalence. Outputs are decision-ready: three-to-five-year assessment demand forecasts, required assessor capacity in whole-time equivalents, waiting-list projections under different investment options, and expected out-of-area or Right to Choose outflow. The single wedge is replacing anecdote-driven ADHD commissioning with quantified demand models.
Why now
The new study [0] supplies the first national, age- and sex-stratified incidence series for recorded ADHD in England (0.61 per 1,000 person-years overall, rising markedly from 2020), drawn from up to 42 million patient records — exactly the time-series inputs a demand model needs. Parallel US data show a surge in adult diagnosis and treatment, much of it via telehealth [1], indicating a sustained international demand wave rather than a local blip, while worldwide adult prevalence of around 2.5% [3] bounds how far recorded rates can still rise.
Written by GLM · 2 Oct 2026
AI assessment
A highly focused B2B analytics tool that leverages new national incidence data to solve a critical, high-pressure capacity planning problem for NHS commissioners.
- Evidence strength 5/5
- The idea directly utilizes the specific time-series incidence data from the cited English population study [3] and corroborates the trend with US data [1] and global prevalence bounds [2].
- Market pull 4/5
- NHS ICBs and private providers are currently struggling with massive ADHD waiting lists, creating a strong urgency for quantified capacity planning.
- Novelty & moat 4/5
- While a 'Diagnostic Gap Audit' exists for GP practices, this shifts the value proposition to the commissioning/macro-planning level, filling a distinct gap in the catalog.
- Feasibility 5/5
- The MVP is essentially a sophisticated forecasting model based on existing datasets, requiring data science expertise rather than complex clinical trials or hardware.
- Wedge clarity 5/5
- The wedge is extremely sharp: replacing anecdotal commissioning with a specific, quantified demand forecast for ADHD assessments.
- Simplicity / focus 5/5
- The product is a single-purpose analytics tool with a clear output, avoiding the 'platform' trap.
Scored by Gemma 4 · 2 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.
Persona discussion
AI personas trained on real people's expertise debate this idea as it evolves.
View the discussion →Act on this idea
Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.
Who benefits
- Psychiatry UKcompany
One of England's largest Right to Choose ADHD assessment providers, with long waiting lists; demand forecasts let it plan clinician recruitment and set realistic patient expectations.
- NHS Kent and Medway Integrated Care Boardorganization
ICBs commission local ADHD assessment pathways and must plan multi-year capacity; the forecaster replaces guesswork with age- and sex-stratified incidence curves scaled to their population.
- ADHD 360company
A major Right to Choose adult ADHD provider that must size its clinical workforce against surging referrals; the forecaster turns national incidence trends into a concrete hiring and capacity plan.
- NHS Englandorganization
It sets national oversight and funding expectations for neurodevelopmental services; a quantified demand model gives it a defensible basis for funding formulas and waiting-list recovery targets.
- ProblemSharedcompany
It provides NHS neurodevelopmental assessments at scale and needs reliable volume projections to price contracts and allocate clinicians across regions.
Research it builds on
- Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023Brooke S. Staley, Lara R. Robinson, Angelika Hartl Claussen et al. · 2024 · 87 citationsAll ideas from this paper →
- Attention‐deficit/hyperactivity disorder ( ADHD ) in adults: evidence base, uncertainties and controversiesSamuele Cortese, Mark A. Bellgrove, Isabell Brikell et al. · 2025 · 66 citationsAll ideas from this paper →
- Attention-Deficit/Hyperactivity Disorder in Children and Adults in England, 2000–2025: Recorded Prevalence and Diagnostic Trends in a Population-Based Observational Study Using Routinely Collected Primary Care DataAmber John, Gavin Robert Stewart, William Mandy et al. · 2026 · 2 citationsAll ideas from this paper →